277 results about "Bupleurum chinense" patented technology

The invention discloses traditional Chinese medicine oral decoction for treating the upper respiratory infection and a preparation method for Chinese patent medicine of the traditional Chinese medicine oral decoction. The Chinese medicine raw material components comprise cassia twig, Chinese herbaceous peony, ginger, Chinese date, born licorice, fritillaria cirrhosa, folium eriobotryae, stir-fried white mulberry root-bark, stir-fried radix stemonae, honeysuckle, rhizoma phragmitis, bupleurum chinense, skullcap, Astragalus membranaceus, saposhnicovia divaricata, gypsum, Radix Ophiopogonis, Dendranthema indicum, purple perilla, folium isatidis, herba schizonepetae, mint, dandelion, houttuynia cordata, herba andrographitis, philippine violet herbs, spreading hedyotis herbs, notopterygium roots, rhizoma cimicifugae, flos magnoliae, radix angelica dahurica, rhizoma belamcandae, burdock, herbs of stickyhair pearleverlasting, platycodon grandiflorum, radix isatidis, fructus forsythiae, radices trichosanthis, medicine terminalia fruit, stir-fried ephedra, radix sophorae tonkinensis and stir-fried tussilago farfara; the traditional Chinese medicine oral decoction is formed by boiling all the components through water. The preparation method for the Chinese patent medicine comprises the steps of weighing, frying of the medicine frying, stir-frying of the medicine, extraction of baicalin, distillate collection, boiling of the rest of the medicine with water, concentration of ethyl alcohol, water adding and filtration, and separated packaging of filter liquor. The traditional Chinese medicine oral decoction for treating the upper respiratory infection and the preparation method for the Chinese patent medicine of the traditional Chinese medicine oral decoction have the advantages of being reasonable in formula, scientific in preparation method, effective in treatment and the like.

The invention discloses a feeding feed for rabbits, which contains the following materials: (1) feeding feeds for rabbit at the age of less than 70 days: corn flour, wheat bran, bean pulp, rice bran, grass meal, pine needle meal, folium mori and Chinese herbal medicine additive; and (2) feeding feeds for rabbits at the age from 70 days to 110 days: corn flour, bean pulp, wheat bran, rice bran, dry grass meal, bee pollen and Chinese herbal medicine additive; according to the invention, different feeds are fed to the rabbits according to the growth period of the rabbits, so that the rabbits grow and develop normally; the Chinese herbal medicine additive in the feed ensures the health and nutrients of the rabbits; spore can activate the immune function of the rabbits, improve the immune capability of the rabbits, strengthen the habitus of the rabbits, and promote the quality of rabbit meat; contents of bee pollen minerals and vitamin are extremely rich, and constant taking of bee pollen minerals and vitamin can promote the odor of the rabbit meat and causes the rabbit meat to be fresher and more tender; and Glabrous Greenbrier Rhizome and Bupleurum chinense mainly play the role of reducing the fat content of the early stage of the rabbit meat, so that the rabbit meat is more tasty.

The invention provides a using method of a full-automatic production line of slices, and belongs to the field of decoction pieces processing devices. The using method comprises the following steps ofcleaning by using an ultrasonic cleaner, shaping by using a root stock shaping machine, slicing by using a reciprocating slicer, elevating and feeding by using a bucket elevator, drying by using a hotair dryer, separating by using a rail-mounted reciprocating separating screen, and storing by using a moistureproof storage tank. Traditional Chinese medicine decoction pieces prepared from the rootstocks of bupleurum chinense realizes automatic assembly line production.

The invention relates to a method for preparing schizonepeta and divaricate saposhnikovia root oral liquid for removing toxin. The method comprises the following steps of: (1) distilling schizonepeta, divaricate saposhnikovia root, incised notopterygium rhizome, heracleum, bitter orange, ligusticum wallichii, whiteflower hogfennel root and mint to extract volatile oil, and collecting an aqueous solution obtained after distillation in a container; (2) treating the decoction dregs of ligusticum wallichii and bitter orange, and tuckahoe by a percolation method to obtain colature, namely adding 25 weight percent of ethanol into the aqueous solution obtained after distillation in the step (1) to obtain a mixture serving as a solvent, performing percolation, collecting colature, and recovering ethanol under reduced pressure; and (3) adding water into decoction dregs of schizonepeta, divaricate saposhnikovia root, incised notopterygium rhizome, heracleum, and whiteflower hogfennel root, and bupleurum chinense, platycodon grandiflorus, and liquorice, and decocting for three times, filtering, mixing filtrate, concentrating until the solution is 1,300ml, mixing the solution and colature which is obtained in the step (2), standing, filtering, concentrating until the solution is 1,000ml, adding 3 parts of sodium benzoate, and the volatile oil which is obtained in the step (1), uniformly stirring, and adding water to ensure the solution is 1,000ml to obtain the oral liquid. Ethanol which is produced when the schizonepeta and divaricate saposhnikovia root oral liquid for removing toxin is produced can be recovered by equipment special for recovering ethanol; the produced decoction dregs can be used for manure collection or agriculture supporting; and waste gases are avoided.

The invention discloses a traditional Chinese medicinal recipe for inhibiting vibrio anguillarum. The recipe is characterized by comprising at least one of fructus schisandrae chinensis, pericarpium granati, folium artemisiae argyi, aloe, aluminis usti, catechu, siegesbeckia pubescens mak, radix sanguisorbae, herba lobeliae chinensis, folium ilex, semen arecae, chaenomeles speciosa, sapium sebiferum, moxibustion myrrha, anemone chinensis, herba artemisiae scopariae, rhizoma arisaematis, radix scutellariae, andrographis paniculata, rhizoma polygoni cuspidate slice, fructus quisqualis, herba taraxaci, hops, herba portulacae, fructus forsythiae, gentiana scabra bunge, rhizoma atractylodis, cortex moutan radicis, semen pharbitidis, flos caryophyllata, herba violae, radix clematidis, solanum nigrum, galla chinensis, leguminosae, herba hedyotis, bupleurum chinense, tetradium ruticarpum, fructus mume, folium isatidis, plantago asiatica L and rhizoma curcumae, wherein a recipe which is formed by mixing the pericarpium granati, the folium artemisiae argyi, the fructus schisandrae chinensis and the aloe according to the mass ratio of 1:4:1:4 has an optimal antibacterial effect. The recipe has the advantages of naturality, no toxity and residues, no tolerance and low price.

A disclosed traditional-Chinese-medicine drunkenness-dispelling liver-protecting beverage is prepared from the following raw materials in parts by weight: 30-60 parts of radix puerariae, 35-50 parts of flower of lobed kudzuvine, 10-25 parts of dry ginger, 15-30 parts of fructus forsythiae, 10-25 parts of fructus amomi, 20-39 parts of radix glycyrrhizae, 30-60 parts of raisin tree seed, 18-30 parts of pericarpium citri reticulatae, 15-30 parts of poria, 10-28 parts of ramulus cinnamomi, 18-35 parts of bupleurum chinense, 5-20 parts of fructus crataegi, 10-28 parts of herba menthae, 8-18 parts of ziziphus jujuba, 15-30 parts of gypsum, and 5-10 parts of a sweetener. The beverage is prepared by decocting the above natural Chinese herbal medicines with different efficacy, and also proper amount of a sweetener is added. The beverage is unique in mouthfeel and refreshing in taste, has the efficacy of clearing heat and detoxifying, relaxing bowels and promoting diuresis, is capable of accelerating alcohol metabolism so as to realize the purposes of dispelling drunkenness and sobering up, and also helps to release uncomfortable feeling such as gastrectasia, nausea, headache and head fullness, mouth thirsty and the like caused by drunkenness, alleviate heart rate acceleration and blood sugar rising caused by excessive drunkenness and prevent liver injury caused by alcohol.

The invention belongs to the field of Chinese medicines and particularly discloses a Chinese medicine for treating rhinitis. The Chinese medicine consists of bupleurum chinense, siberian cocklour fruit, ligusticum wallichii, scutellaria baicalensis, tuckahoe, honeysuckle flower, divaricate saposhnikovia root, angelica dahurica, weeping forsythia, dried tangerine, chrysanthemum, Chinese magnoliavine fruit, small centipeda herb, biond magnolia flower, cassia twig, mint, dried ginger, and atractylodes lancea which serve as active ingredients in a certain weight part ratio. The Chinese medicine is specially used for treating rhinitis, multiple kinds of medicines are matched appropriately, and a curative effect is improved by using synergistic or resistant effects among the medicines to adapt to the treatment requirement of complex disease conditions, and reduce an adverse effect, and the Chinese medicine is safe and reliable, is easy to take and has a better curative effect on rhinitis. 80 patients are treated, and the total effective rate can reach 95 percent.

The invention relates to a traditional Chinese medicine composition for treating myasthenia gravis. The traditional Chinese medicine composition concretely comprises the following raw medicinal materials in parts by weight: 120-180 parts of astragalus membranaceus, 20-50 parts of radix pseudostellariae, 30-60 parts of codonopsis pilosula, 20-30 parts of bighead atractylodes rhizome, 6-10 parts of bupleurum chinense, 6-10 parts of rhizoma cimicifugae, 6-10 parts of angelica sinensis, 20-50 parts of Chinese yam, 6-10 parts of cortex albiziae, 15-40 parts of prepared fleece flower root, 6-20 parts of morinda officinalis, 6-20 parts of mulberry, 3-6 parts of liquorice, 3-6 parts of pericarpium citri reticulatae, 3-6 parts of fructus aurantii, 20-30 parts of caulis spatholobi, 10-20 parts of medlar and 5-12 parts of radix ophiopogonis. The traditional Chinese medicine composition can be used for strengthening the middle warmer and benefiting vital energy, strengthening the spleen and tonifying the kidneys, and soothing the liver and regulating qi as to a patient with myasthenia gravis, and clinical cure is achieved.

The invention relates to 'Xiaoyao' sugar functional candies and a preparation technology thereof. The 'Xiaoyao' sugar functional candies comprise the following active ingredients in part by weight: 15 parts of bupleurum chinense, 15 parts of Chinese angelica, 6 parts of mint, 15 parts of white paeony root, 15 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 15 parts of ginger and 6 parts of roasted liquorice. The preparation process comprises the following steps of: crushing the raw materials; extracting by using alcohol water; spray-drying at a supersonic speed; performing nano-scale crushing; homogenizing at high temperature; and freeze-drying and the like. The 'Xiaoyao' sugar functional candies have effects of resisting depression, protecting the liver and the like. According to requirements of the candy preparation technology, different varieties of candies can be prepared selectively.

The invention discloses a traditional Chinese medicinal oral preparation for treating chicken coccidiosis. The traditional Chinese medicinal oral preparation consists of the following traditional Chinese medicinal raw materials in parts by weight: 1-3 parts of radix dichroae, 1-3 parts of areca catechu, 1-3 parts of Chinese pulsatilla root, 1-2 parts of Szechwan chinaberry fruit, 1-3 parts of bupleurum chinense, 1-3 parts of cortex phellodendri chinensis, 1-3 parts of radix astragali and 1-2 parts of root of pilose asiabell. The traditional Chinese medicinal oral preparation is safe and reliable and overcomes the limitation of chemical medicines. The traditional Chinese medicinal oral preparation can be taken with water, is orally taken to be quickly absorbed, and has the characteristics of obvious and exact curative effect, no medicine residue and no toxic and side effects.

The invention discloses a medicine for treating depression, and a preparation method thereof. The medicine is prepared from bupleurum chinense, root of red-rooted salvia, acorus gramineus, thinleaf milkwort rootbark, zedoary, coptis chinensis, dragon bone, oyster, and chlorite schist in a certain weight part proportion; bupleurum chinense, root of red-rooted salvia, acorus gramineus, thinleaf milkwort rootbark, zedoary and coptis chinensis are extracted by a percolation method, dragon bone, oyster, and chlorite schist are extracted by a levigation method, then extracts are mixed, and mixed extracts and auxiliary materials are mixed to be prepared into any common oral formulation. The medicine has the effects of soothing the liver and regulating vital energy, activating blood and dissolving stasis, tranquilizing the mind, reducing phlegm and purging fire and the like, is used for treating liver qi stagnation, vexation and sleeplessness and other symptoms, and is also used for treating depression.

The invention relates to a method for controlling the quality of a standardized extract of a Chinese herbal medicine, i.e., the quality standard of standardized bupleurum extract. The method comprises the following steps: the bupleurum chinense is extracted in the semi-bionic environment, the total content of the main effective components (saikosaponin a, saikosaponin b, saikosaponin c and saikosaponin d) of the extract is equal to or greater than 1.874 percent, and the total content is equal to or greater than 1.3 percent according to the standard content index. The quality standard of the standardized bupleurum extract includes identification of bupleurum extract, content determination of saikosaponins, specific chromatogram determination and other detection items. The main components of the bupleurum extract can be determined qualitatively and quantitatively, the unified and controllable quality and the standardize production of the bupleurum extract can be ensured, the pharmaceutical quality and the therapeutic effect of the bupleurum extract are guaranteed, and a new quality standard is formulated for completely and accurately evaluating the quality of the standardized bupleurum extract on the basis of experimental research. The method has the characteristics of simplicity, convenience, stability and good reproducibility, and is favorable for improving the inspection efficiency.

The invention relates to a traditional Chinese medicine which is suitable for parturient women with hypogalactia during lactation, a preparation method and a detection method thereof. According to the invention, Chinese angelica and Astragalus mongholicus are used as the principal drugs, Bupleurum Chinense and Ligusticum wallichii are used as the ministerial drugs, and Vaccaria segetalis, MedullaTetrapanacis and Fructus Liquidambaris are used as the adjuvant drugs. The traditional Chinese medicine provided by the invention has functions of tonifying qi and nourishing blood, relieving qi stagnancy in liver, and dredging collateral for promoting lactation, and can be used to treat symptoms such as postpartum hypogalactia or lactation deficiency; or clear and thin breast milk; or pale complexion, mental fatigue and deprivation; or hypochondriac and distending pains as well as depressed mood.

The invention discloses a Chinese medicine for treating fowl plague. The Chinese medicine is characterized by consisting of the following components in part by weight: 21 to 36 parts of realgar, 20 to 50 parts of schizonepeta, 20 to 50 parts of honeysuckle, 20 to 50 parts of bupleurum chinense, 20 to 50 parts of kudzuvine root, 20 to 50 parts of scutellaria baicalensis, 20 to 50 parts of akebia stem, 20 to 50 parts of indigowoad root, 20 to 50 parts of liquorice, 20 to 50 parts of folium isatidis, and 20 to 50 parts of dried ginger. The Chinese medicine has an obvious effect of preventing and treating swine fever.

The invention discloses a traditional Chinese medicine composition for treating insomnia, anxiety, depression and climacteric syndrome, and a preparation method thereof. The traditional Chinese medicine composition comprises the following traditional Chinese medicine raw materials in parts by weight: 200-800 parts of cornus officinalis, 200-800 parts of schisandra chinensis, 100-500 parts of spinadate seeds, 100-500 parts of radix paeoniae alba, 100-500 parts of rehmannia, 50-250 parts of lotus plumule, 100-500 parts of moutan bark, 100-400 parts of rhizoma anemarrhenae, 100-400 parts of bupleurum chinense, and 100-400 parts of fried gardenia. Due to the synergistic effect generated by the efficacy of various drugs, the traditional Chinese medicine composition in the invention has the effects of nourishing yin, tonifying kidney, clearing away heart-fire, calming nerves and soothing liver-qi stagnation, and is used for insomnia, amnesia, chest distress, palpitation, inappetence, trance, dreaminess, easiness in waking up, fatigue, irritability, dizziness and tinnitus caused by deficiency of liver-yin and kidney-yin and heart-kidney imbalance, and insomnia, dreaminess, hot flush, sweating, dizziness and tinnitus caused by climacteric syndrome, so that insomnia, anxiety, depression and climacteric syndrome are effectively treated.

The invention discloses decoction for treating canker sore. The decoction is prepared from the following Chinese herbal medicines: 10 to 20g of honeysuckle, 10 to 20g of scutellaria baicalensis, 10 to 15g of weeping forsythia, 10 to 15g of astragalus, 5 to 10g of codonopsis pilosula, 5 to 10g of angelica sinensis, 10 to 20g of root of rehmannia, 10 to 20g of Chinese yam, 5 to 15g of tuckahoe, 5 to 15g of bupleurum chinense, 3 to 10g of dogwood, and 10 to 20g of liquorice. The decoction is prepared by mixing all the Chinese herbal medicines, adding water and decocting for 30 to 40 minutes, andfiltering to obtain filtrate, namely the decoction for treating canker sore. One dose of the decoction can be orally taken each day, one treatment course is five days, and canker sore can be cured after one to two treatment courses. The decoction has the effect of treating various crank sore such as toxin mouth sore during external infection, spleen and stomach heat sore, spleen-kidney yang deficiency sore and the like and has a good curative effect; and the raw materials are low in price and easy to obtain, and the treatment cost is low.

The invention discloses oral liquid for reducing phlegm and relieving cough. The oral liquid is prepared from the raw materials in parts by weight: 5-15 parts of ginger processed pinellia, 10-20 parts of astragalus membranaceus, 5-15 parts of red paeony roots, 15-25 parts of dwarf lilyturf tubers, 5-15 parts of fructus forsythia, 15-25 parts of the root of kudzu vine, 10-25 parts of Chinese galls and 5-15 parts of bupleurum chinense. The oral liquid is used for oral administration, has functions of eliminating dampness and phlegm, dispelling wind and heat, promoting the secretion of saliva or body fluid, relieving cough and asthma and relaxing bowel, is mainly used for treating symptoms of much cough, asthma, throat tumor, lung heat and phlegm stagnation, and yellow and viscous phlegm, and is safe and reliable and free of toxic or side effects.

The present invention discloses a breast cancer treatment traditional Chinese medicine, and belongs to the field of traditional Chinese medicines. The breast cancer treatment traditional Chinese medicine is prepared from the following raw materials: 20 g of trichosanthes kirilowii maxim, 20 g of milkvetch root, 20 g of common selfheal spike, 20 g of oyster, 15 g of bupleurum chinense, 15 g of scutellaria baicalensis georgi, 15 g of curcuma aromatica salisb., 15 g of angelica, 15 g of immature tangerine fruit, 15 g of white peony root, 15 g of balloonflower root, 15 g of szechwan lovage rhizome, 10 g of bulbus fritillariae cirrhosae, 10 g of dandelion, 10 g of stiff silkworm, 10 g of ginseng, 10 g of fructus aurantii, 10 g of magnolia officinalis, 10 g of angelica archang lica, 10 g of saposhnikovia divaricata, 10 g of lindera aggregata, 10 g of pangolin, 6 g of tangerine peel, 6 g of akabia stem, and 6 g of licorice root. The breast cancer treatment traditional Chinese medicine has effects of healthy energy supporting, qi reinforcing, blood nourishing, spleen strengthening, liver soothing, blood stasis dissipating, detoxication, good chemotherapy reaction alleviating and cancer recurrence and metastasis prevention so as to increase the comprehensive treatment effect and achieve the purposes of patient symptom improvement and complete cancer cell killing.

The invention relates to a preparation process of integration-type novel formulation of DACHAIHU decoction and a production method thereof. The effective components of the novel formulation are made from the following raw materials (by weight parts): Radix Bupleuri (Bupleurum chinense and / or Bupleurum scorzonerifolium) 15, Scutellaria baicalensis 9, Paeonia lactiflora 9, Pinellia ternate 9, Zingiber officinale 15, Fructus Aurantii Immaturus (Citrus aurantium and / or Citrus sinensis) 9, Ziziphus jujuba (Fructus Jujubae) 4 and Radix Et Rhizoma Rhei 6. The production method includes the steps of supersonic airstream pulverization, alcohol-water extraction, ultrasonic pulverization and extraction, water decoction and concentration, supersonic spray-drying, nano-scale grinding, high-pressure emulsion and homogenization and nanoparticle preparation. The production method integrates the advantageous of the nano-carrier combination technique, such as multi-component synergism and multi-target. The large-scale production can greatly reduce the production cost, greatly improve the product quality and enhance the target property and sustained / controlled-release property of drugs. The novel formulation is administered by oral intake and external application during four time periods respectively based on the midnight-noon tidal flow and human qi-blood flow rule. The novel formulation is also processed to membranes and transdermal delivery agents which are applied to different parts of human body respectively according to the midnight-noon tidal flow and human qi-blood flow rule and can be directly absorbed by the skin.

The invention relates to a traditional Chinese medicine for treating the insomnia, which is prepared by the following active pharmaceutical ingredients by weight: 5-10g of cortex albiziae, 3-5g of shelled cedar seed, 10-20g of dragon bone fossilized powder, 6-12g of radix astragali, 8-15g of pearl shell, 3-5g of radix salviae miltiorrhizae, 3-5g of flower bud of Japanese apricot, 4-6g of liquorice, 4-8g of white atractylodes rhizome, 5-10g of tuckahoe, 2-5g of cortex moutan, 2-4g of radix paeoniae alba and 8-10g of bupleurum chinense. The traditional Chinese medicine for treating the insomnia disclosed by the invention can treat the insomnia caused by various symptoms, and has lower cost and no toxic or side effect. In the invention, the clinically effective rate is 80%, and the curative ratio is 75%.

The invention discloses a Chinese medicinal composition for treating chloasma. The Chinese medicinal composition comprises an oral medicine and an externally applied medicine. The oral medicine consists of the following powdery Chinese herbal medicines in part by weight: 6.5 to 9.5 parts of Angelica sinensis, 6 to 9.5 parts of root of red-rooted salvia, 6.5 to 9.5 parts of bupleurum chinense, 6.5to 15 parts of tuckahoe, 6 to 9 parts of sinkiang arnebia root, 6.5 to 15 parts of alisma plantagoaquatica, 6.5 to 9.5 parts of wax gourd seed, 6.5 to 9.5 parts of angelica dahurica, 6.5 to 9.5 partsof Chinese trumpet creeper, 6.5 to 9.5 parts of rose, 6.5 to 9.5 parts of hibiscus, 6.5 to 9.5 parts of lotus, 6.5 to 9.5 parts of peach blossom, 6.5 to 9.5 parts of bletilla striata, 6.5 to 15 partsof Chinese yam, 3.5 to 6.5 parts of safflower, and 3.5 to 6.5 parts of liquorice; and the externally applied medicine consists of the lowing Chinese herbal medicines in part by weight: 20 to 40 partsof bletilla striata, 20 to 40 parts of angelica dahurica, 10 to 20 parts of safflower, and 15 to 30 parts of root of red-rooted salvia. The invention has the advantages that: chloasma is treated by combining the oral medicine and the externally applied medicine, and the Chinese medicinal composition has a better treatment effect than a single medicine.

The invention provides an oral Chinese medicine for treating epilepsy. The oral Chinese medicine comprises the following components in part by weight: 7 to 11 parts of peach seed, 7 to 11 parts of safflower, 7 and 11 parts of angelica sinensis, 7 to 11 parts of ligusticum wallichii, 7 to 11 parts of root of rehmannia, 9 to 15 parts of red paeony root, 9 to 15 parts of white paeony root, 7 to 11 parts of bupleurum chinense, 7 to 11 parts of bitter orange, 4 to 8 parts of platycodon grandiflorum, 9 to 15 parts of achyranthes bidentata, 9 to 15 parts of stiff silkworm, 9 to 15 parts of geosaurus, and 4 to 8 parts of liquorice. Compared with the prior art, the oral Chinese medicine can treat epilepsy by differentiation from symptoms and signs aiming at internal pathogenic factors of epilepsy, has quick response, and an obvious effect, is low in cost and does not have toxic or side effect and addresses both the symptoms and root causes.

The invention relates to the technical field of Chinese herbal medicine planting and particularly discloses a method for planting bupleurum chinense. The bupleurum chinense is planted in a greenhouse, and a transparent glass culture box is arranged at the top end of the greenhouse. The method includes the following steps of seed treatment, seed cutting and branching, growth management and spaced harvesting. A culture solution is contained in the glass culture box, and algae plants are bred in the culture solution. The method in the base case has the advantages that the algae plants are subjected to color light distribution according to the growth period of the bupleurum chinense, and pertinent light absorption of the bupleurum chinense is promoted; by means of the biological regulation capacity of the algae plants, the temperature difference in the greenhouse is reduced, and the environment is more suitable for growth of the bupleurum chinense; the bred algae plants can serve as new crop output, and crop planting diversification is promoted.

The invention discloses a method for preparing a bupleurum chinense injection. A process for preparing the bupleurum chinense injection comprises the following steps of: extracting a supercritical product taking a bupleurum chinense volatile oil as a main component by using a CO<2> supercritical extraction technique; purifying the supercritical product by a distillation method; and after adding an HP-Beta-CD into the obtained distillate for cladding, adding a corresponding pharmaceutical adjuvant to prepare the bupleurum chinense injection. The process for preparing the bupleurum chinense injection provided by the invention can correctly perform qualitative and quantitative analysis on the volatile oil which is contained in a medicament, and meanwhile, can increase the yield of the bupleurum chinense volatile oil, improve the dissolubility of the bupleurum chinense volatile oil, increase the stability of the medicament, promote medicament absorption and improve bioavailability on the basis of not changing pharmaceutical materials.

The invention relates to the technical field of cash crop cultivation and specifically relates to a cultivation method of interplanting bupleurum chinense with corn. The method comprises following steps: (1) seed selection; (2) land selection and preparation; (3) Bupleurum chinense seed treatment; (4) seeding; (5) irrigation; (6) field management; (7) control of diseases and insect pests; (8) timely harvesting. The cultivation method of the present application provides more shading for Bupleurum, ensures the emergence and yield of Bupleurum, and is simple, convenient and cost-effective to operate.

The invention belongs to the technical field of traditional Chinese medicines, and relates to a dampness-clearing lung-ventilating traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following components in parts by mass: 5 to 10 parts of raw ephedra herb, 25 to 30 parts of gypsum, 5 to 12 parts of semen armeniacae amarae, 10 to 16 parts of rhizomaanemarrhenae, 10 to 16 parts of radix bupleuri chinensis, 10 to 16 parts of rhizoma seu radix notopterygii, 10-16 parts of rhizoma atractylodis, 10-16 parts of wrinkled gianthyssop herb and 5-12 partsof medicated leaven. The invention further provides application of the dampness-clearing lung-ventilating traditional Chinese medicine composition in preparation of a medicine for treating community-acquired pneumonia, especially viral pneumonia or suspected COVID-19. The dampness-clearing lung-ventilating traditional Chinese medicine composition of the invention can be used as a medicine for treating suspected cases of COVID-19 to cut off and reverse an illness state in an early stage and prevent deterioration and development of the illness state.

The invention discloses a method for extracting saikosaponin from bupleurum chinense by using a two-level foam separation process, which relates to an extraction and separation method of the saikosaponin. The method comprises the following steps: drying and crushing the bupleurum chinense decoction pieces; extracting by using a solvent cold-soaking method; filtering to obtain the coarse extract liquid of the saikoside; recycling the solvent from the coarse extract liquid; separating the obtained saponin aqueous liquid serving as an initial liquid into a first-level foam separation tower; crushing foams of a foam layer, and stopping charge of gas when the foam cannot flow out of the top of the foam separation tower, wherein the foam which is crushed and flows out of the top of the foam separation tower is adopted as a first-level de-foaming liquid; separating the residual liquid in the tower which is adopted as the feeding liquid of the second-level foam separation in a second-level foam separation tower, wherein the foam flowing out of the top of the tower after being crushed is adopted as a second-level de-foaming liquid; stopping charge of gas when the foam cannot flow out of the top of the foam separation tower; mixing the second-level de-foaming liquid with the coarse extract liquid of saikoside, and then adding the mixture into the feeding liquid of the first-level foam separation tower; evaporating the de-foaming liquid in vacuum to obtain the concentrated liquid; and adjusting pH value to be subalkaline, freezing and drying to obtain the product.

A traditional Chinese medicine for treating climacteric syndrome is prepared from the following medicinal materials: Rehmannia glutinosa, Salvia miltiorrhiza, blighted wheat, Ziziphus jujuba (Fructus Jujubae), Curculigo orchioides, Herba Epimedii, Radix Bupleuri (Bupleurum chinense and / or Bupleurum scorzonerifolium), Angelica sinensis, Paeonia lactiflora (Radix Paeoniae Alba), Poria cocos, Atractylodes macrocephala, Glycyrrhiza uralensis and Morinda officinalis. The first dose of the above medicinal materials are decocted in 700 mL of water to 200 mL, and the second dose of the above medicinal materials are decocted in 500 mL of water to 200 mL. The traditional Chinese medicine is taken twice a day at morning and night on an empty stomach.

The invention provides a method for improving the hairy root induction efficiency and the genetic transformation efficiency of bupleurum chinense, and application thereof. On the basis of exploration on the conditions of the hairy root agrobacterium strains, the infection bacteria liquid OD value, the co-culture time and the like, the optimum combination condition for improving the infection efficiency of the hairy root agrobacterium is determined; compared with the traditional hairy root induction efficiency being about 10 percent, the hairy root induction efficiency obtained by the technical scheme provided by the invention reaches 70 to 85 percent. The method for improving the hairy root genetic transformation efficiency of the bupleurum chinense provided by the invention has the advantages that the exogenous gene conversion rate being 80 percent or higher can be obtained; better, more efficient, simpler and more convenient selection is provided for the bupleurum chinense functional gene research and / or the industrialization of hairy root metabolites of the bupleurum chinense.